Advertisement
Advertisement
HRTX
Heron Therapeutics, Inc.
1.21
USDSponsored
-0.03
-2.42%
May 08, 15:53 UTC -4
Closed
After-Market
1.23
+0.02
+1.24%
HRTX Earnings Reports
Positive Surprise Ratio
HRTX beat 21 of 40 last estimates.
53%
Next Report
Tomorrow BMO
Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
$39.12M
/-$0.01
Implied change from Q4 25 (Revenue/ EPS)
-3.62%
/-50.00%
Implied change from Q1 25 (Revenue/ EPS)
+0.55%
/-200.00%
Heron Therapeutics, Inc. earnings per share and revenue
On Feb 26, 2026, HRTX reported earnings of -0.02 USD per share (EPS) for Q4 25, beating the estimate of -0.02 USD, resulting in a 1.96% surprise. Revenue reached 40.59 million, compared to an expected 40.32 million, with a 0.65% difference. The market reacted with a +7.19% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -0.01 USD, with revenue projected to reach 39.12 million USD, implying an decrease of -50.00% EPS, and decrease of -3.62% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Collegium Pharmaceutical, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$1.62
Actual
$1.76
Surprise
+8.43%
Xeris Biopharma Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+296.08%
Ironwood Pharmaceuticals, Inc. - Class A
Report Date
May 07, 2026 For Q1 26
Estimate
$0.24
Actual
$0.24
Surprise
-1.96%
SIGA Technologies Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
Profound Medical Corp. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+25.75%
OmniAb, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.06
Surprise
+41.18%
ZOETIS INC.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.63
Actual
$1.53
Surprise
-6.19%
Stevanato Group S.p.A.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.10
Actual
$0.11
Surprise
+5.45%
Crinetics Pharmaceuticals, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.26
Actual
-$1.23
Surprise
+2.51%
NewAmsterdam Pharma Company N.V. Ordinary Shares
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.50
Actual
-$0.40
Surprise
+20.32%
FAQ
What were Heron Therapeutics, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Heron Therapeutics, Inc. reported EPS of -$0.02, beating estimates by 1.96%, and revenue of $40.59M, 0.65% above expectations.
How did the market react to Heron Therapeutics, Inc.'s Q4 2025 earnings?
The stock price moved up 7.19%, changed from $1.39 before the earnings release to $1.49 the day after.
When is Heron Therapeutics, Inc. expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for Heron Therapeutics, Inc.'s next earnings report?
Based on --
analysts, Heron Therapeutics, Inc. is expected to report EPS of -$0.01 and revenue of $39.12M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement